Skip to main content

Advertisement

Log in

Interaction of misonidazole and WR-2721—II. Modification of tumour radiosensitization

  • Original Article
  • Published:
British Journal of Cancer Submit manuscript

Abstract

Two types of mouse tumour have been used to study the radiomodifying actions of Misonidazole (MISO) and WR-2721 when used alone and in combination with each other. Single dose studies were performed in both of the tumours and fractionated studies were performed on the anaplastic carcinoma, CA MT. Radioprotection with WR-2721 was seen in both tumours, being most marked at low X-ray doses. The protection was more obvious and the sensitization by MISO less in the fractionated experiment. The combination of MISO and WR-2721 gave an intermediate response compared with either drug used alone, resulting in some sensitization with single doses and an overall protection with repeated small doses. An interactive toxicity of the 2 drugs was also observed, suggesting an additive effect when assessed in terms of lethality. These studies indicate that the effects of both MISO and WR-2721 are dependent upon the oxygen status of the cells in the tumour, and that MISO can act in an oxygen-mimetic manner to modify the radioprotection observed with WR-2721.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rojas, A., Stewart, F. & Denekamp, J. Interaction of misonidazole and WR-2721—II. Modification of tumour radiosensitization. Br J Cancer 47, 65–72 (1983). https://doi.org/10.1038/bjc.1983.8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1983.8

  • Springer Nature Limited

This article is cited by

Navigation